Industry: Service & Software
Published Date: 2026-03-01
Pages: 120 Pages
Report ld: 6001516
Request Sample
Customized Report
Single Cell Genomics and Proteomics Market Size(US$)

CAGR 2026-2032
5.3%
Market Size,2032
USD 325
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Single Cell Genomics and Proteomics market was valued at US$ 226 million in 2025 and is anticipated to reach US$ 325 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Single-cell genomics and proteomics are cutting-edge technologies for elucidating molecular mechanisms at single-cell resolution. Single-cell genomics amplifies and sequences the entire genome or targeted regions of a single cell, revealing DNA sequence variations, copy number changes, and lineage relationships. It is primarily used to study tumor heterogeneity and mutation accumulation during development. Single-cell proteomics, on the other hand, focuses on identifying and quantifying thousands of proteins within a single cell, directly reflecting the cell's functional state through ultra-sensitive mass spectrometry or novel affinity reagent technologies. The two complement each other: genomics reveals "what might happen," while proteomics reveals "what is happening," jointly advancing the precise understanding of cellular heterogeneity and functional status.
The global development of Single Cell Genomics and Proteomics presents a competitive landscape led by the US and Europe, with the Asia-Pacific region catching up. The US, leveraging its top institutions and instrument companies, dominates single-cell genomics sequencing platforms and high-throughput screening technologies, continuously pushing the limits of throughput and multimodal data fusion. Europe, relying on its strong tradition in proteomics and mass spectrometry, possesses unique advantages in micro-sample preparation, post-translational modification detection, and standardized algorithms for single-cell proteomics. The Asia-Pacific region, with China at its core, focuses on clinical translation and large-scale population cohorts. Through cost-effective domestic platforms and vast sample resources, it is rapidly producing landmark results in tumor heterogeneity and developmental atlases, moving from technology users to rule-makers.
This report delivers a comprehensive overview of the global Single Cell Genomics and Proteomics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Single Cell Genomics and Proteomics. The Single Cell Genomics and Proteomics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Single Cell Genomics and Proteomics market comprehensively. Regional market sizes by Type, by Application, by Scenarios, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Single Cell Genomics and Proteomics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Scenarios, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Single Cell Genomics and Proteomics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Cell Genomics and Proteomics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Cell Isolation
1.2.3 Sample Preparation
1.2.4 Genomic Analysis
1.3 Market by Scenarios
1.3.1 Global Single Cell Genomics and Proteomics Market Size Growth Rate by Scenarios: 2021 vs 2025 vs 2032
1.3.2 Tumor Research
1.3.3 Developmental Biology
1.3.4 Neuroscience
1.3.5 Clinical Diagnostics
1.3.6 Others
1.4 Market by Technology
1.4.1 Global Single Cell Genomics and Proteomics Market Size Growth Rate by Technology: 2021 vs 2025 vs 2032
1.4.2 Sequencing/Amplification-Based Technology
1.4.3 Mass Spectrometry-Based Technology
1.5 Market by Application
1.5.1 Global Single Cell Genomics and Proteomics Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Genomic Variation
1.5.3 Subpopulation Characterization
1.5.4 Circulating Tumor Cells
1.5.5 Cell Differentiation
1.5.6 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Single Cell Genomics and Proteomics Market Perspective (2021–2032)
2.2 Global Single Cell Genomics and Proteomics Growth Trends by Region
2.2.1 Global Single Cell Genomics and Proteomics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Single Cell Genomics and Proteomics Historic Market Size by Region (2021–2026)
2.2.3 Single Cell Genomics and Proteomics Forecasted Market Size by Region (2027–2032)
2.3 Single Cell Genomics and Proteomics Market Dynamics
2.3.1 Single Cell Genomics and Proteomics Industry Trends
2.3.2 Single Cell Genomics and Proteomics Market Drivers
2.3.3 Single Cell Genomics and Proteomics Market Challenges
2.3.4 Single Cell Genomics and Proteomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Cell Genomics and Proteomics Players by Revenue
3.1.1 Global Top Single Cell Genomics and Proteomics Players by Revenue (2021–2026)
3.1.2 Global Single Cell Genomics and Proteomics Revenue Market Share by Players (2021–2026)
3.2 Global Top Single Cell Genomics and Proteomics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Single Cell Genomics and Proteomics Revenue
3.4 Global Single Cell Genomics and Proteomics Market Concentration Ratio
3.4.1 Global Single Cell Genomics and Proteomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Cell Genomics and Proteomics Revenue in 2025
3.5 Global Key Players of Single Cell Genomics and Proteomics Head Offices and Areas Served
3.6 Global Key Players of Single Cell Genomics and Proteomics, Products and Applications
3.7 Global Key Players of Single Cell Genomics and Proteomics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Single Cell Genomics and Proteomics Breakdown Data by Type
4.1 Global Single Cell Genomics and Proteomics Historic Market Size by Type (2021–2026)
4.2 Global Single Cell Genomics and Proteomics Forecasted Market Size by Type (2027–2032)
5 Single Cell Genomics and Proteomics Breakdown Data by Application
5.1 Global Single Cell Genomics and Proteomics Historic Market Size by Application (2021–2026)
5.2 Global Single Cell Genomics and Proteomics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Single Cell Genomics and Proteomics Market Size (2021–2032)
6.2 North America Single Cell Genomics and Proteomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Single Cell Genomics and Proteomics Market Size by Country (2021–2026)
6.4 North America Single Cell Genomics and Proteomics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single Cell Genomics and Proteomics Market Size (2021–2032)
7.2 Europe Single Cell Genomics and Proteomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Single Cell Genomics and Proteomics Market Size by Country (2021–2026)
7.4 Europe Single Cell Genomics and Proteomics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Single Cell Genomics and Proteomics Market Size (2021–2032)
8.2 Asia-Pacific Single Cell Genomics and Proteomics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Single Cell Genomics and Proteomics Market Size by Region (2021–2026)
8.4 Asia-Pacific Single Cell Genomics and Proteomics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Single Cell Genomics and Proteomics Market Size (2021–2032)
9.2 Latin America Single Cell Genomics and Proteomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Single Cell Genomics and Proteomics Market Size by Country (2021–2026)
9.4 Latin America Single Cell Genomics and Proteomics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Cell Genomics and Proteomics Market Size (2021–2032)
10.2 Middle East & Africa Single Cell Genomics and Proteomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Single Cell Genomics and Proteomics Market Size by Country (2021–2026)
10.4 Middle East & Africa Single Cell Genomics and Proteomics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10x Genomics, Inc.
11.1.1 10x Genomics, Inc. Company Details
11.1.2 10x Genomics, Inc. Business Overview
11.1.3 10x Genomics, Inc. Single Cell Genomics and Proteomics Introduction
11.1.4 10x Genomics, Inc. Revenue in Single Cell Genomics and Proteomics Business (2021–2026)
11.1.5 10x Genomics, Inc. Recent Development
11.2 Standard BioTools Inc
11.2.1 Standard BioTools Inc Company Details
11.2.2 Standard BioTools Inc Business Overview
11.2.3 Standard BioTools Inc Single Cell Genomics and Proteomics Introduction
11.2.4 Standard BioTools Inc Revenue in Single Cell Genomics and Proteomics Business (2021–2026)
11.2.5 Standard BioTools Inc Recent Development
11.3 QIAGEN GmbH
11.3.1 QIAGEN GmbH Company Details
11.3.2 QIAGEN GmbH Business Overview
11.3.3 QIAGEN GmbH Single Cell Genomics and Proteomics Introduction
11.3.4 QIAGEN GmbH Revenue in Single Cell Genomics and Proteomics Business (2021–2026)
11.3.5 QIAGEN GmbH Recent Development
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Details
11.4.2 Thermo Fisher Scientific Inc. Business Overview
11.4.3 Thermo Fisher Scientific Inc. Single Cell Genomics and Proteomics Introduction
11.4.4 Thermo Fisher Scientific Inc. Revenue in Single Cell Genomics and Proteomics Business (2021–2026)
11.4.5 Thermo Fisher Scientific Inc. Recent Development
11.5 Agilent Technologies, Inc.
11.5.1 Agilent Technologies, Inc. Company Details
11.5.2 Agilent Technologies, Inc. Business Overview
11.5.3 Agilent Technologies, Inc. Single Cell Genomics and Proteomics Introduction
11.5.4 Agilent Technologies, Inc. Revenue in Single Cell Genomics and Proteomics Business (2021–2026)
11.5.5 Agilent Technologies, Inc. Recent Development
11.6 Exact Sciences Corporation
11.6.1 Exact Sciences Corporation Company Details
11.6.2 Exact Sciences Corporation Business Overview
11.6.3 Exact Sciences Corporation Single Cell Genomics and Proteomics Introduction
11.6.4 Exact Sciences Corporation Revenue in Single Cell Genomics and Proteomics Business (2021–2026)
11.6.5 Exact Sciences Corporation Recent Development
11.7 Accelerate Diagnostics, Inc.
11.7.1 Accelerate Diagnostics, Inc. Company Details
11.7.2 Accelerate Diagnostics, Inc. Business Overview
11.7.3 Accelerate Diagnostics, Inc. Single Cell Genomics and Proteomics Introduction
11.7.4 Accelerate Diagnostics, Inc. Revenue in Single Cell Genomics and Proteomics Business (2021–2026)
11.7.5 Accelerate Diagnostics, Inc. Recent Development
11.8 Bio-Rad Laboratories, Inc.
11.8.1 Bio-Rad Laboratories, Inc. Company Details
11.8.2 Bio-Rad Laboratories, Inc. Business Overview
11.8.3 Bio-Rad Laboratories, Inc. Single Cell Genomics and Proteomics Introduction
11.8.4 Bio-Rad Laboratories, Inc. Revenue in Single Cell Genomics and Proteomics Business (2021–2026)
11.8.5 Bio-Rad Laboratories, Inc. Recent Development
11.9 Epic Sciences, Inc.
11.9.1 Epic Sciences, Inc. Company Details
11.9.2 Epic Sciences, Inc. Business Overview
11.9.3 Epic Sciences, Inc. Single Cell Genomics and Proteomics Introduction
11.9.4 Epic Sciences, Inc. Revenue in Single Cell Genomics and Proteomics Business (2021–2026)
11.9.5 Epic Sciences, Inc. Recent Development
11.10 Yikon Genomics Co., Ltd.
11.10.1 Yikon Genomics Co., Ltd. Company Details
11.10.2 Yikon Genomics Co., Ltd. Business Overview
11.10.3 Yikon Genomics Co., Ltd. Single Cell Genomics and Proteomics Introduction
11.10.4 Yikon Genomics Co., Ltd. Revenue in Single Cell Genomics and Proteomics Business (2021–2026)
11.10.5 Yikon Genomics Co., Ltd. Recent Development
11.11 Takara Bio Inc.
11.11.1 Takara Bio Inc. Company Details
11.11.2 Takara Bio Inc. Business Overview
11.11.3 Takara Bio Inc. Single Cell Genomics and Proteomics Introduction
11.11.4 Takara Bio Inc. Revenue in Single Cell Genomics and Proteomics Business (2021–2026)
11.11.5 Takara Bio Inc. Recent Development
11.12 1CellBio, Inc.
11.12.1 1CellBio, Inc. Company Details
11.12.2 1CellBio, Inc. Business Overview
11.12.3 1CellBio, Inc. Single Cell Genomics and Proteomics Introduction
11.12.4 1CellBio, Inc. Revenue in Single Cell Genomics and Proteomics Business (2021–2026)
11.12.5 1CellBio, Inc. Recent Development
11.13 Bio-Techne Corporation
11.13.1 Bio-Techne Corporation Company Details
11.13.2 Bio-Techne Corporation Business Overview
11.13.3 Bio-Techne Corporation Single Cell Genomics and Proteomics Introduction
11.13.4 Bio-Techne Corporation Revenue in Single Cell Genomics and Proteomics Business (2021–2026)
11.13.5 Bio-Techne Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Single Cell Genomics and Proteomics market is projected to grow from US$ 226 million in 2025 to US$ 325 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-01
Pages: 143
USD 4900.00
(Single User License)
The global Single Cell Genomics and Proteomics market size was US$ 226 million in 2025 and is forecast to reach a readjusted size of US$ 325 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-03-01
Pages: 92
USD 4250.00
(Single User License)
The global market for Single Cell Genomics and Proteomics was estimated to be worth US$ 226 million in 2025 and is projected to reach US$ 325 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-01
Pages: 103
USD 3950.00
(Single User License)
The global Single Cell Genomics and Proteomics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 158
USD 4900.00
(Single User License)
The global Single Cell Genomics and Proteomics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 106
USD 4250.00
(Single User License)
The global market for Single Cell Genomics and Proteomics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 124
USD 3950.00
(Single User License)
The global market for Single Cell Genomics and Proteomics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 99
USD 2900.00
(Single User License)
Market Analysis and Insights: Global Single Cell Genomics and Proteomics Market
Published Date: 2024-04-08
Pages: 119
USD 4900.00
(Single User License)
The global market for Single Cell Genomics and Proteomics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-22
Pages: 133
USD 3950.00
(Single User License)
The global Single Cell Genomics and Proteomics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-06
Pages: 90
USD 2900.00
(Single User License)
The global Single Cell Genomics and Proteomics market is projected to grow from US$ 226 million in 2025 to US$ 325 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-01
Pages: 143
The global Single Cell Genomics and Proteomics market size was US$ 226 million in 2025 and is forecast to reach a readjusted size of US$ 325 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-03-01
Pages: 92
The global market for Single Cell Genomics and Proteomics was estimated to be worth US$ 226 million in 2025 and is projected to reach US$ 325 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-01
Pages: 103
The global Single Cell Genomics and Proteomics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 158
The global Single Cell Genomics and Proteomics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 106
The global market for Single Cell Genomics and Proteomics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 124
The global market for Single Cell Genomics and Proteomics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 99
Market Analysis and Insights: Global Single Cell Genomics and Proteomics Market
Published: 2024-04-08
Pages: 119
The global market for Single Cell Genomics and Proteomics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-22
Pages: 133
The global Single Cell Genomics and Proteomics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-06
Pages: 90
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now